Biovays is advancing the field of biomarker-based drug R&D and continues to be an industry-leading CRO.

Now for a limited time, Biovays is offering a ten percent (10%) rebate on all new contracts, only through IguanaBio!

More on Biovays

Biovays is a pioneering biotechnology CRO that boasts unique savoir-faire in the expression, localization and quantification of biomarkers. Biovays provides flexible, fully customized services within the constraints of the project environment – meeting client demands for accuracy, timeliness and cutting-edge research. Harnessing state-of-the-art technology and expertise in molecular imaging, Biovays offers powerful analytical tools to several industries – opening up new possibilities for the screening of drug candidates.

Via tailor-made protocols and a range of highly specialized models, Biovays helps clients leverage benefits and focus on their core business. From target discovery through to FDA approval, Biovays’ innovative quantitative biomarker analysis streamlines drug development and boosts drug approval success rates.

For more information on Biovays, visit their website at www.biovays.com. For more information on our special rebate offer, click here.

Image from biovays

Related Posts